High Performance Liquid Chromatography HPLC Device Sales

High Performance Liquid Chromatography HPLC Device Sales Market Outlook

The global High Performance Liquid Chromatography (HPLC) device market is anticipated to reach approximately USD 3.5 billion by 2035, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2025 to 2035. This substantial growth is driven by the increasing demand from various sectors such as pharmaceuticals, biotechnology, and environmental testing, which require accurate and efficient separation and analysis of compounds. As regulatory bodies continue to tighten standards for quality and safety, the necessity for HPLC devices in quality control and research and development becomes paramount. Moreover, the integration of advanced technologies in HPLC, including automation and miniaturization, is set to enhance efficiency and reduce analysis time, thereby propelling market growth. The advent of personalized medicine and biologics also contributes to the rising demand for HPLC devices, as these innovations necessitate sophisticated analytical methods for drug development and testing.

Growth Factor of the Market

The growth factors contributing to the HPLC device market are multifaceted, primarily stemming from the expanding pharmaceutical and biotechnology sectors, which rely heavily on HPLC for drug formulation and quality control. Furthermore, the increasing focus on food safety and environmental sustainability has led to a surge in demand for HPLC devices in food and beverage testing as well as in environmental monitoring. Another significant factor driving growth is the continuous advancements in HPLC technology, including the rise of ultra-high-performance liquid chromatography (UHPLC), which offers enhanced resolution and speed in analyses. Additionally, the growing need for personalized medicine necessitates precise analytical techniques that can be efficiently achieved with HPLC systems. The rising trend of outsourcing laboratory services is also beneficial, as it provides laboratories access to sophisticated HPLC equipment without significant capital investment, thus fostering market expansion.

Key Highlights of the Market

• Projected market size of USD 3.5 billion by 2035, growing at a CAGR of 6.5%.
• Increased demand from pharmaceutical and biotechnology industries.
• Growing focus on food safety and environmental testing.
• Advancements in HPLC technology, particularly UHPLC.
• Rising trend of outsourcing laboratory services contributing to market growth.

By Product Type

Benchtop HPLC Devices:

Benchtop HPLC devices are widely used in research laboratories due to their robustness and versatility. They are designed for routine analysis and can handle a variety of sample types, making them suitable for both academic and industrial applications. The user-friendly interface and compact design of benchtop HPLC devices allow researchers to conduct experiments efficiently without occupying significant laboratory space. Additionally, advancements in technology have improved their performance, allowing for faster analysis times and greater accuracy. These devices are particularly favored in pharmaceutical laboratories for drug testing and quality assurance, thus contributing to their strong market presence.

Portable HPLC Devices:

Portable HPLC devices are increasingly gaining traction due to their ability to deliver high-quality analysis in field settings. Designed to be lightweight and user-friendly, these devices enable researchers and technicians to conduct tests on-site, which is particularly beneficial for environmental monitoring and food safety applications. The portability of these devices allows for immediate data collection and analysis, significantly enhancing operational efficiency. They are equipped with advanced features that ensure accuracy and reliability, making them valuable tools for laboratories focusing on rapid testing and quality control in various sectors.

Preparative HPLC Devices:

Preparative HPLC devices are specifically designed for the separation and purification of larger quantities of compounds. These devices play a crucial role in pharmaceuticals, where large-scale production and purification of compounds are necessary. They offer high resolution and yield, making them essential in the development stage of drug manufacturing. The growing trend towards biologics and personalized medicine has further increased the demand for preparative HPLC devices, as these technologies enable the efficient isolation of active pharmaceutical ingredients. Continuous improvements in the efficiency and reliability of preparative systems are expected to drive further growth in this segment.

High Pressure Liquid Chromatography (HPLC) Devices:

High Pressure Liquid Chromatography (HPLC) devices are foundational to the chromatography market, providing precise and efficient separation of compounds in various matrices. Their versatility allows them to be employed in diverse applications, including pharmaceuticals, clinical diagnostics, and environmental analysis. The advancements in HPLC technology have led to the development of more efficient and user-friendly systems, which are increasingly capable of handling complex sample matrices. As regulatory demands become more stringent in pharmaceutical and environmental sectors, the importance of high-pressure systems is amplified, leading to sustained growth in this segment.

Fast Protein Liquid Chromatography (FPLC) Devices:

Fast Protein Liquid Chromatography (FPLC) devices are specialized for the purification of proteins and other biomolecules, making them integral to biotechnology and pharmaceutical research. Their design allows for rapid separation and increased efficiency in the isolation of proteins, which is critical in the development of biopharmaceuticals. With the growing focus on therapeutic proteins and biologics, the demand for FPLC devices is expected to rise. These systems offer high resolution and speed, enabling researchers to obtain pure samples quickly, thus facilitating accelerated drug development processes and enhancing their appeal in laboratories focused on bioprocessing.

By Application

Pharmaceuticals:

The pharmaceutical industry represents a significant application area for HPLC devices, as they are essential in drug development, quality control, and regulatory compliance. HPLC techniques are extensively utilized for the analysis of active pharmaceutical ingredients (APIs) and excipients, ensuring product safety and efficacy. The need for stringent quality assurance measures and the increasing complexity of drug formulations necessitate the use of advanced HPLC technology. Additionally, the rise of personalized medicine and biologics is further driving the demand for HPLC in pharmaceutical applications, as these innovations require precise analytical techniques for their development and monitoring.

Biotechnology:

In the biotechnology sector, HPLC devices play a crucial role in the characterization and purification of biological molecules, including proteins, nucleic acids, and other biomolecules. The technological advancements in HPLC have contributed to their increasing adoption in various biotechnological applications, including protein expression analysis and monoclonal antibody development. As the biotechnology industry continues to expand, driven by innovations in therapeutics and diagnostics, the demand for HPLC systems is expected to grow significantly. Their ability to provide high resolution and specificity in analyses supports the rigorous requirements of biotech research, thereby positioning HPLC as a fundamental tool in the sector.

Clinical Diagnostics:

Clinical diagnostics is another vital application area for HPLC devices, where they are employed for the analysis of biological samples, including blood, urine, and tissues. HPLC plays a crucial role in the detection and quantification of biomarkers and metabolites, aiding in disease diagnosis and monitoring treatment efficacy. The increasing prevalence of chronic diseases and the growing focus on personalized healthcare are propelling the demand for HPLC systems in clinical laboratories. Additionally, advancements in HPLC technology enhance the speed and accuracy of diagnostic tests, reinforcing the importance of HPLC devices in the clinical diagnostics field.

Environmental Testing:

Environmental testing is an emerging application for HPLC devices, driven by the growing need for monitoring pollutants and contaminants in air, water, and soil. HPLC systems are employed to analyze a wide range of environmental samples, ensuring compliance with environmental regulations and standards. The increasing awareness of environmental issues and the need for sustainable practices are leading to heightened scrutiny of pollutants, further amplifying the demand for HPLC in this sector. Advancements in HPLC technology also facilitate the analysis of complex environmental matrices, allowing for more efficient and accurate monitoring of contaminants, thus supporting environmental protection efforts.

Food and Beverage Testing:

Food and beverage testing is a critical application for HPLC devices, given the rising consumer demand for food safety and quality assurance. HPLC is utilized to analyze food products for contaminants, additives, and nutritional content, ensuring compliance with safety regulations. The increasing incidences of foodborne illnesses and the need for accurate labeling are driving the adoption of HPLC technology in food laboratories. Furthermore, advancements in HPLC methodologies are improving the efficiency and accuracy of food analyses, thereby enhancing consumer safety and confidence in food products.

By Distribution Channel

Direct Sales:

Direct sales represent a significant distribution channel for HPLC devices, allowing manufacturers to establish a direct relationship with end-users. This approach enables companies to provide tailored solutions and support, enhancing customer satisfaction. Direct sales channels often facilitate better communication regarding product specifications, technical support, and after-sales services. As laboratories increasingly seek personalized solutions to meet their specific analytical needs, the direct sales model is expected to remain prevalent in the HPLC device market.

Distributor Sales:

Distributor sales play a crucial role in the HPLC device market, as they provide broader market access and reach for manufacturers. Distributors often possess extensive networks and local expertise, enabling them to effectively cater to diverse customer needs across different regions. This channel is particularly beneficial for smaller laboratories or institutions that may not have the resources to directly engage with manufacturers. The ability of distributors to provide localized support and service further enhances their role in the market, contributing to the overall growth of HPLC device sales.

By Technology

Ultra-high-performance liquid chromatography (UHPLC):

Ultra-high-performance liquid chromatography (UHPLC) represents a significant advancement in HPLC technology, offering enhanced resolution, speed, and sensitivity in analyses. UHPLC systems utilize smaller particle sizes and higher pressures to achieve faster separation, which is critical in high-throughput laboratories. The increasing emphasis on analytical efficiency and the need for rapid results in pharmaceuticals and clinical diagnostics drive the adoption of UHPLC technology. Additionally, the ability to analyze complex samples with high precision solidifies UHPLC's position as a leading technology in the chromatography market.

Reverse-phase HPLC:

Reverse-phase HPLC is one of the most widely utilized chromatographic techniques, particularly in pharmaceuticals and biochemistry for the separation of non-polar to moderately polar compounds. The technique's versatility allows it to be applied across various applications, including drug analysis and environmental testing. As researchers increasingly require high-resolution separation of complex mixtures, reverse-phase HPLC continues to be a staple in analytical laboratories. The development of advanced stationary phases and optimized conditions further enhances the performance of reverse-phase systems, driving their sustained popularity.

Normal-phase HPLC:

Normal-phase HPLC is often employed for the separation of polar compounds and has a unique application in the analysis of natural products and pharmaceuticals. This technique utilizes a polar stationary phase and a non-polar mobile phase, making it effective for separating compounds based on polarity. The growing interest in natural products and herbal medicines is expected to boost the demand for normal-phase HPLC systems. Additionally, advancements in column technology and mobile phase optimization are enhancing the performance of normal-phase systems, contributing to their relevance in modern analytical chemistry.

Ion-exchange chromatography:

Ion-exchange chromatography is a vital technique for the separation of charged biological molecules, such as proteins and nucleic acids. This method is widely used in biotechnology and pharmaceuticals for protein purification and analysis. The demand for ion-exchange chromatography is expected to grow as the focus on biopharmaceuticals and therapeutics increases, necessitating precise techniques for the isolation of active ingredients. The continuous improvements in ion-exchange materials and protocols are enhancing the effectiveness of this technique, ensuring its ongoing significance in laboratory applications.

Size-exclusion chromatography:

Size-exclusion chromatography (SEC) is a critical technique for the separation of molecules based on size, commonly used in the analysis of polymers, proteins, and other macromolecules. SEC is particularly valuable in the characterization of biopharmaceuticals, as it allows for the determination of molecular weight and aggregation state. The growing biopharmaceutical sector is driving the demand for size-exclusion chromatography systems, as they provide essential data for formulation and stability studies. Innovations in SEC materials and methodologies are expected to further enhance its application in various scientific fields.

By Region

North America holds a dominant position in the HPLC device market, accounting for approximately 40% of the total market share in 2025. The region's robust pharmaceutical and biotechnology industries significantly contribute to market growth, driven by the increasing need for advanced analytical techniques in drug development and quality assurance. North America's focus on research and development, supported by substantial investments in healthcare and laboratory infrastructure, is expected to maintain a steady growth rate of around 6.8% CAGR throughout the forecast period. Furthermore, the presence of leading HPLC manufacturers and a well-established distribution network enhance the region's market dynamics.

Europe follows North America, contributing about 30% to the global HPLC device market. The region is characterized by stringent regulatory requirements, emphasizing the need for precise analytical methods in pharmaceuticals and environmental testing. The increasing emphasis on food safety and quality assurance is also driving the demand for HPLC systems in Europe. As the region continues to focus on innovation and sustainability, the HPLC market is projected to grow at a CAGR of 6.2% from 2025 to 2035, reflecting the increasing adoption of advanced chromatography technologies.

Opportunities

The HPLC device market presents several opportunities, particularly in emerging economies where the pharmaceutical and biotechnology sectors are rapidly growing. These regions are experiencing an increasing demand for sophisticated analytical instruments to support drug development and quality control processes. Manufacturers have the opportunity to expand their market presence by offering tailored solutions that cater to the unique needs of laboratories in these regions. Additionally, collaborations with local distributors and research institutions can enhance market penetration and foster innovation by adapting technologies to local requirements. Furthermore, the growing trend of personalized medicine and biologics is creating opportunities for HPLC manufacturers to innovate and develop advanced systems that can meet the specific analytical challenges associated with these therapeutic approaches.

Another significant opportunity lies in the integration of automation and digitalization in HPLC systems. The adoption of smart laboratory technologies, including data management systems and automated sample handling, is transforming traditional laboratory practices. By incorporating these advancements, HPLC manufacturers can offer users enhanced efficiency, reduced analysis times, and streamlined workflows. As laboratories increasingly seek to optimize their operations, there is a growing demand for HPLC systems that can seamlessly integrate with laboratory information management systems (LIMS) and facilitate real-time data analysis. This integration will not only enhance productivity but also improve the overall accuracy and reliability of analytical results, positioning manufacturers to capitalize on this trend.

Threats

Despite the promising growth prospects in the HPLC device market, certain threats could impede progress. One of the primary threats is the rapid technological advancements that necessitate constant innovation and adaptation by manufacturers. Companies that fail to keep pace with emerging technologies such as ultra-high-performance liquid chromatography (UHPLC) or automated systems risk losing market share to more agile competitors. Additionally, the economic fluctuations and uncertainties in global markets can impact laboratory budgets and funding for research initiatives, potentially leading to reduced capital investment in sophisticated analytical equipment. Moreover, the increasing competition from alternative separation techniques and instruments could pose a challenge to the traditional HPLC market, as laboratories may opt for newer, more cost-effective solutions.

Another significant threat is the stringent regulatory landscape governing laboratory practices and product quality in various regions. Compliance with regulations can be a burdensome process for manufacturers, requiring substantial investments in quality assurance, documentation, and reporting. Failure to meet regulatory requirements can lead to product recalls, legal issues, and reputational damage. Furthermore, the global shift towards sustainable and environmentally friendly practices is influencing laboratory operations, requiring manufacturers to adapt their technologies to align with these changing standards. This shift presents both challenges and opportunities, and manufacturers must navigate this landscape carefully to ensure compliance while maintaining product performance and reliability.

Competitor Outlook

• Agilent Technologies
• Thermo Fisher Scientific
• Waters Corporation
• PerkinElmer
• Shimadzu Corporation
• Hitachi High-Technologies
• Jasco, Inc.
• Knauer Wissenschaftliche Geräte GmbH
• Bio-Rad Laboratories
• Gilson, Inc.
• Repligen Corporation
• Sciex
• GE Healthcare Life Sciences
• Mettler Toledo
• Merck KGaA

The competitive landscape of the HPLC device market is characterized by the presence of several key players that dominate the industry through innovation, extensive product portfolios, and strong customer relationships. Agilent Technologies and Thermo Fisher Scientific are recognized leaders, offering a wide range of HPLC systems and solutions catering to various applications, including pharmaceuticals, biotechnology, and clinical diagnostics. These companies continually invest in research and development to enhance their product offerings, focusing on advanced technologies like ultra-high-performance liquid chromatography (UHPLC) and automated solutions. By prioritizing customer support and training, these market leaders maintain a competitive edge and foster long-term relationships with their clients.

Waters Corporation is another significant player in the HPLC market, known for its dedication to developing cutting-edge chromatography technologies. The firm's commitment to innovation has led to numerous breakthroughs in separation science, solidifying its reputation as a go-to provider of HPLC instruments. Additionally, Waters' strong emphasis on sustainability and environmental responsibility resonates well with the modern laboratory's needs, positioning the company favorably in the market. The firm's comprehensive range of products, including column technologies and data management systems, further enhances its competitive position.

Shimadzu Corporation and PerkinElmer are also vital contributors to the HPLC landscape, offering a diverse array of products and solutions tailored to various analytical needs. Shimadzu, with its focus on precision and reliability, provides advanced HPLC systems that cater to the pharmaceutical and environmental sectors. PerkinElmer, on the other hand, emphasizes the integration of innovative technologies into its HPLC devices, ensuring that users can achieve optimal performance and efficiency. Both companies are proactive in expanding their global presence, targeting emerging markets to meet the increasing demand for analytical instruments.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Sciex
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Merck KGaA
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Jasco, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 PerkinElmer
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Gilson, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Mettler Toledo
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Waters Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Agilent Technologies
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Bio-Rad Laboratories
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Repligen Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Shimadzu Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Thermo Fisher Scientific
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Hitachi High-Technologies
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 GE Healthcare Life Sciences
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Knauer Wissenschaftliche Geräte GmbH
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 High Performance Liquid Chromatography HPLC Device Sales Market, By Technology
    • 6.1.1 Ultra-high-performance liquid chromatography (UHPLC)
    • 6.1.2 Reverse-phase HPLC
    • 6.1.3 Normal-phase HPLC
    • 6.1.4 Ion-exchange chromatography
    • 6.1.5 Size-exclusion chromatography
  • 6.2 High Performance Liquid Chromatography HPLC Device Sales Market, By Application
    • 6.2.1 Pharmaceuticals
    • 6.2.2 Biotechnology
    • 6.2.3 Clinical Diagnostics
    • 6.2.4 Environmental Testing
    • 6.2.5 Food and Beverage Testing
  • 6.3 High Performance Liquid Chromatography HPLC Device Sales Market, By Product Type
    • 6.3.1 Benchtop HPLC Devices
    • 6.3.2 Portable HPLC Devices
    • 6.3.3 Preparative HPLC Devices
    • 6.3.4 High Pressure Liquid Chromatography (HPLC) Devices
    • 6.3.5 Fast Protein Liquid Chromatography (FPLC) Devices
  • 6.4 High Performance Liquid Chromatography HPLC Device Sales Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 High Performance Liquid Chromatography HPLC Device Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global High Performance Liquid Chromatography HPLC Device Sales market is categorized based on

By Product Type

• Benchtop HPLC Devices
• Portable HPLC Devices
• Preparative HPLC Devices
• High Pressure Liquid Chromatography (HPLC) Devices
• Fast Protein Liquid Chromatography (FPLC) Devices

By Application

• Pharmaceuticals
• Biotechnology
• Clinical Diagnostics
• Environmental Testing
• Food and Beverage Testing

By Distribution Channel

• Direct Sales
• Distributor Sales

By Technology

• Ultra-high-performance liquid chromatography (UHPLC)
• Reverse-phase HPLC
• Normal-phase HPLC
• Ion-exchange chromatography
• Size-exclusion chromatography

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Agilent Technologies
• Thermo Fisher Scientific
• Waters Corporation
• PerkinElmer
• Shimadzu Corporation
• Hitachi High-Technologies
• Jasco, Inc.
• Knauer Wissenschaftliche Geräte GmbH
• Bio-Rad Laboratories
• Gilson, Inc.
• Repligen Corporation
• Sciex
• GE Healthcare Life Sciences
• Mettler Toledo
• Merck KGaA